Pharma Stock Roundup: PFE Booster Works on Omicron, AZN COVID Cocktail Gets FDA Nod

Retrieved on: 2024-04-14 16:27:31

Tags for this article:

COVID-19 drug development

Monoclonal antibodies

COVID-19 vaccination in the United States

RNA vaccines

Research and development in the United States

Bamlanivimab/etesevimab

Bamlanivimab

Pfizer-BioNTech COVID-19 vaccine

Post-exposure prophylaxis

Moderna COVID-19 vaccine

Emergency use authorization

COVID-19 vaccine

Click the tags to see associated articles and topics

Pharma Stock Roundup: PFE Booster Works on Omicron, AZN COVID Cocktail Gets FDA Nod. View article details on hiswai:

Summary

The article discusses recent advancements in COVID-19 drug development, such as the effectiveness of Pfizer-BioNTech's booster against Omicron and the emergency use authorization of monoclonal antibody treatments like AstraZeneca's Evusheld and Eli Lilly's bamlanivimab/etesevimab for COVID-19 prevention and pediatric use.

Article found on: uk.movies.yahoo.com

View Original Article